Sort:
Open Access Just Accepted
Distinct effects of highland barley and common buckwheat on gut microbiota and liver transcriptomics in high-fat diet-induced mice
Food Science and Human Wellness
Available online: 29 September 2026
Abstract PDF (1 MB) Collect
Downloads:4

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver condition, influenced by factors such as obesity, insulin resistance, and hyperlipidemia. While ancient grains like highland barley (HB) and common buckwheat (BW) have shown potential to mitigate these factors, direct comparisons of their effects on NAFLD remain unclear. The present study investigated the impact of HB and BW on HFD-induced NAFLD and the underlying mechanisms, including the influence of gut microbiota and fecal metabolic profile. HB supplementation for 12 weeks significantly reduced fat accumulation, serum triglycerides, insulin resistance, and hepatic steatosis visualized through H&E staining. BW supplementation also reduced these parameters, though less pronouncedly. Besides, HB and BW altered the gut microbiota composition, enriched the abundance of probiotics, while reducing harmful bacteria. Specifically, HB increased the abundance of Ileibacterium and norank_f_Muribaculaceae, while reducing that of Mucispirillum and Helicobacter. BW elevated levels of Akkermansia and Lachnospiraceae_UCG-001, and lowered those of Mucispirillum and norank_f_Peptococcaceae. In addition, HB supplementation greatly increased fecal levels of succinic acid and L-aspartic acid, whereas BW supplementation raised levels of 2,3-dihydroxybenzoic acid, p-salicylic acid, pyrocatechol, and gentisic acid. Moreover, liver transcriptomic analysis revealed that HB upregulated LEPR, AMPKα1, and PGC-1α, while BW enhanced PI3K, AKT, and BCL-2 expression. Overall, HB and BW alleviated HFD-induced NAFLD through distinct modulation of gut microbiota, fecal metabolites, and hepatic transcriptomic profiles.

Open Access Review Issue
Progress in the Study of the Role of Grain Proteins and Peptides in Regulating the Therapeutic Targets for Type 2 Diabetes
Food Science 2022, 43(9): 310-316
Published: 15 May 2022
Abstract PDF (2.2 MB) Collect
Downloads:2

In recent years, numerous studies have demonstrated that grain proteins and peptides derived from their enzymatic hydrolysis such as dipeptidyl peptidase-4 (DPP-Ⅳ), glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and related enzymes can act on the therapeutic targets for type 2 diabetes mellitus (T2DM) and thereby improve T2DM. This article gives a summary of recent research on the beneficial effect of grain proteins and peptides on T2DM, and discusses future prospects for the application of grain proteins and peptides in T2DM treatment.

Open Access Issue
Dietary Dose Conversion of Whole Grains and Non-soy Legumes between Mice and Humans
Food Science 2025, 46(2): 118-125
Published: 25 January 2025
Abstract PDF (4.8 MB) Collect
Downloads:3

Moderate intake of whole grains and non-soy legumes can improve glucose and lipid metabolism, but excessive intake may have an adverse effect. Due to the lack of corresponding conversion relationships, the intake of whole grains and non-soy legumes in mouse feed cannot directly serve as a reference for human intake. This paper introduces the addition levels of common whole grains and non-soy legumes in mouse feed and explores their relationship with the recommended dietary intakes (RDI) of common whole grains and non-soy legumes in humans using various methods, including equivalent coefficient, surface area ratio, body shape coefficient, food density, body surface area index, energy conversion, and nutrient conversion methods. The results indicate that the RDI of 50–150 g of whole grains and non-soy legumes in humans could be equivalently converted into addition of 5%–50% whole grains and beans in the feed of mice with a 3 g daily feed intake. Dietary addition of whole grains and non-soy legumes exceeding 50% might place mice at risk for overconsumption. This study provides an important reference for establishing the conversion relationship between the amounts of whole grains and non-soy legumes added to mouse feed and the RDI of whole grains and non-soy legumes in humans.

Open Access Research Article Just Accepted
A comparison between millet and quinoa supplementation on hepatic steatosis, gut microbiota in high-fat diet-induced mice
Food Science and Human Wellness
Available online: 11 July 2025
Abstract PDF (3.2 MB) Collect
Downloads:47

Nonalcoholic fatty liver disease (NAFLD), the most common kind of ongoing liver disease, is influenced by a diverse combination of pathogenic factors including obesity, insulin resistance, and hyperlipemia. Foxtail millet (FM) and quinoa (QA) are common small whole-grain cereals that may decrease the risk of these chronic diseases. In this study, their differences concerning hepatic steatosis, and their targets for modulating gut microbiota and its metabolites in relation to NAFLD were investigated for the first time. After 12 weeks, FM supplementation reduced liver fat accumulation, weight gain and serum triglycerides (TG), while enhancing insulin sensitivity. Similarly, QA supplementation decreased hepatic lipid deposition and ameliorated hyperlipidemia. Both of them modulated gut microbiota composition: FM increased the relative abundance of Faecalibaculum and norank_f_Muribaculaceae, whereas QA enriched Lactobacillus, Akkermansia, and norank_f_Muribaculaceae. In addition, FM had greater effects on fecal metabolic function, significantly elevating levels of L-aspartic acid and melatonin while reducing that of PA(16:0/15:0) and phenyllactic acid. QA similarly lowered PA(16:0/15:0) and phenyllactic acid concentrations. Findings suggest that the potentials to alleviate high-fat diet (HFD)-induced NAFLD were associated with improvements in gut microbiota and metabolic function.

Open Access Research Article Issue
Alteration of fecal microbiome and metabolome by mung bean coat improves diet-induced non-alcoholic fatty liver disease in mice
Food Science and Human Wellness 2022, 11(5): 1259-1272
Published: 02 June 2022
Abstract PDF (1.6 MB) Collect
Downloads:162

Dysbiosis of gut microbiota and its derived metabolites has been linked to the occurrence and development of nonalcoholic fatty liver disease. Our previous study has demonstrated that mung bean coat (MBC) might be mainly responsible for the beneficial effects of whole mung bean on high fat diet (HFD)-induced metabolic disorders. To investigate whether MBC, which is rich in dietary fiber and phytochemicals, can protect against HFD-induced hepatic steatosis in mice via targeting gut microbiota and its metabolites, we conducted this study. Results showed that MBC could effectively alleviative the obese phenotype, reduce the lipid accumulation and insulin resistance, and improve the hepatic oxidative stress and inflammatory response. Furthermore, MBC significantly prevented the HFD-induced changes in the structure and composition of gut microbiota, characterized by promoting the bloom of Akkermansia, Lachnospiraceae_NK4A136_group, and norank_f_Muribaculaceae, and along with the elevated short-chain fatty acids concentrations. Non-targeted metabolomic analysis indicated a metabolism disorder that was obviously improved by MBC via regulating sphingolipid metabolism and α-linolenic acid metabolism. These findings suggested that MBC could improve hepatic steatosis through manipulating the crosstalk between gut microbiota and its metabolites.

Open Access Research Article Issue
Foxtail millet supplementation improves glucose metabolism and gut microbiota in rats with high-fat diet/streptozotocin-induced diabetes
Food Science and Human Wellness 2022, 11(1): 119-128
Published: 11 September 2021
Abstract PDF (525.8 KB) Collect
Downloads:157

Foxtail millet (FM) whole grain has received special attention in recent years. To confirm the hypoglycemic effects of FM, we investigated the effects of FM supplementation on glucose metabolism and gut microbiota in rats with high-fat diet/streptozotocin (HFD/STZ)-induced diabetes. Specifically, we fully assessed the blood biochemical profiles, pancreatic histopathology, insulin-glucagon immunofluorescence, short-chain fatty acids, and gut microbiota composition of rats with HFD/STZ-induced diabetes before and after FM supplementation. Results showed that both 30% and 48% FM supplementation significantly decreased concentrations of fasting blood glucose, 60-min blood glucose, and blood triglycerides (P < 0.05); additionally, 48% FM supplementation significantly improved blood glucose tolerance and insulin resistance (P < 0.05). However, FM supplementation could not effectively repair damage to β-cells over a short period of time. In addition, 4 weeks of 48% FM supplementation siginificantly increased the relative abundance of Bifidobacterium and concentration of butyrate, suggesting that the hypoglycemic effects of FM supplementation might be partially mediated by gut microbiota. Collectively, we found a dose-dependent relationship between FM supplementation and improvement of blood glucose metabolism, but did not find a synergistic effect between FM supplementation and metformin (Met) treatment. Our findings provide further support that consuming more whole-grain FM might be beneficial to individuals suffering from type 2 diabetes.

Total 6